DS
TECX

David Shaw’s Tectonic Therapeutic TECX Stock Holding History

David Shaw’s Portfolio TECX Stock Details TECX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.41M Buy
186,550
+70,430
+61% +$2.07M ﹤0.01% 2197
2026
Q1 		$3.59M Sell
116,120
-4,130
-3% -$102K ﹤0.01% 2431
2025
Q4 		$2.51M Buy
+120,250
New +$2.23M ﹤0.01% 2869
2022
Q4 		– Sell
-8,137
Closed -$63K – 5187
2022
Q3 		$63K Sell
8,137
-29,267
-78% -$325K ﹤0.01% 4663
2022
Q2 		$413K Sell
37,404
-2,700
-7% -$31.8K ﹤0.01% 4209
2022
Q1 		$635K Buy
40,104
+35,148
+709% +$726K ﹤0.01% 4224
2021
Q4 		$229K Buy
+4,956
New +$285K ﹤0.01% 4814
2020
Q3 		– Sell
-1,495
Closed -$313K – 4232
2020
Q2 		$313K Buy
+1,495
New +$308K ﹤0.01% 3611

Other funds holding TECX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

David Shaw's TECX Position: Q2 2026 in Review

David Shaw increased its Tectonic Therapeutic (TECX) stake by 61% in Q2 2026, buying an estimated $2.07M and bringing the position to 186,550 shares worth $6.41M. The position accounts for ﹤0.01% of the portfolio, ranked #2197.

David Shaw first reported a position in TECX in Q2 2020 and has held it in 8 quarters since. 122 funds tracked by Wall St. Rank hold TECX as of Q2 2026.

  • David Shaw held 186,550 shares of Tectonic Therapeutic worth $6.41M as of Q2 2026.
  • David Shaw bought 70,430 Tectonic Therapeutic shares in Q2 2026, an estimated $2.07M.
  • Tectonic Therapeutic made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #2197 holding.
  • David Shaw first reported a position in Tectonic Therapeutic in Q2 2020 and has held it in 8 quarters since.
  • 122 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.